2 ML lanadelumab-flyo 150 MG/ML Prefilled Syringe
RxNorm concept 2593416, clinical drug (scd). Prescribable name: lanadelumab-flyo 300 MG in 2 ML Prefilled Syringe.
- RxCUI
- 2593416
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2593416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
lanadelumab-flyo 150 MG/ML per 2 ML Prefilled Syringe; lanadelumab-flyo 300 MG per 2 ML Prefilled Syringe
Related concepts
- lanadelumab-flyo 150 MG/ML (SCDC, consists of)
- Prefilled Syringe (DF, has dose form)
- 2 ML lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2593416 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2593416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2593416. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.